Determination of Etoposide Serum Concentrations in Small Pediatric Samples by an Improved Method of Reversed-Phase High-Performance Liquid Chromatography

Acta Medica Okayama

Volumn 57, Issue 1, 2003, Pages 21-24

  Kato, Yasuhiro ^a,b   Mawatari, Hideo ^b   Nishimura, Shin Ichiro ^b   Sakura, Nobuo ^b   Ueda, Kazuhiro ^b  

^a National Hiroshima Hospital   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Etoposide; Reversed phase high performance liquid chromatography; Serum concentration

Indexed keywords

ETOPOSIDE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CENTER; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; MEASUREMENT; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; ULTRAVIOLET RADIATION; BLOOD; CALIBRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETOPOSIDE; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 0042285954     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Clark PI, Slevin ML, Joel SP, Osborne RJ, Talbot DI, Johnson PWM, Reznek R, Masud T, Gregory W and Wrigley PFM: A randomized trial of two etoposide schedules in small-cell lung cancer: The influence of pharmacokinetics on efficacy and toxicity. J Clin Oncol (1994) 12: 1427-1435.
2. Harvey VJ, Joel SP, Johnston A and Slevin ML: High-performance liquid chromatography of etoposide in plasma and urine. J Chromatogr (1985) 339: 419-423.
3. Lowis SP, Pearson ADJ, Newell DR and Cole M: Etoposide pharmacokinetics in children: The development and prospective validation of a dosing equation. Cancer Res (1993) 53: 4881-4889.
4. Bennett CL, Sinkule JA, Schilsky RL, Senekjian E and Choi KE: Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer. Cancer Res (1987) 47: 1952-1956.
5. Miller AA, Stewart CF and Tolley EA: Clinical pharmacodynamics of continuous-infusion etoposide. Cancer Chemother Pharmacol (1990) 25: 361-366.
6. Ratain MJ, Mick R, Schilsky RL, Vogelzang NJ and Berezin F: Pharmacologically based dosing of etoposide: A means of safely increasing dose intensity. J Clin Oncol (1991) 9: 1480-1486.
7. Strife RJ, Jardine I and Colvin M: Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography. J Chromatogr (1980) 182: 211-220.
8. Farina P, Marzillo G and D'Incalci M: High-performance liquid chromatography determination of 4′-demethyl-epipodophyllotoxin-9-(4,6-0- ethylidene β-D-glucopyranoside) (VP 16-213) in human plasma. J Chromatogr (1981) 222: 141-145.
9. Strife RJ, Jardine I and Colvin M: Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1981) 224: 168-174.
10. Duncan GF, Farmen RH, Movahhed HS and Pittman KA: High-performance liquid chromatographic method for the determination of etoposide in plasma using electrochemical detection. J Chromatogr (1986) 380: 357-365.
11. Chow D, Shah J and Chen JR: Stability-indicating high-performance liquid chromatography of etoposide at various pH conditions using a reversed-phase octyl column. J Chromatogr (1987) 396: 217-223.
12. Werkhoven-Goewie CE, Brinkman UAT, Frei RW, De Ruiter C and De Vries J: Automated liquid chromatographic analysis of the anti-tumorigenic drugs etoposide (VP 16-213) and teniposide (VM 26). J Chromatogr (1983) 276: 349-357.
13. Holthuis JJM, Van Oort WJ and Pinedo HM: A sensitive high-performance liquid chromatographic method for determination of the anti-neoplastic agents VP 16-213 and VM 26 in biological fluids. Anal Chim Acta (1981) 130: 23-30.
14. Boos J, Krümpelmann S, Schulze-Westhoff P, Euting T, Berthold F and Jürgens H: Steady-state levels and bone marrow toxicity of etoposide in children and infants: Does etoposide require age-dependent dose calculation? J Clin Oncol (1995) 13: 2954-2960.
15. Sinkule JA and Evans WE: High-performance liquid chromatographic analysis of the semisynthetic epipodophyllotoxins teniposide and etoposide using electrochemical detection. J Pharm Sci (1984) 73: 164-168.
16. Saita T, Fujiwara K, Kitagawa T, Mori M and Takata K: A highly sensitive enzyme-linked immunosorbent assay for etoposide using β-D-galactosidase as a label. Cancer Chemother Pharmacol (1990) 27: 115-120.
17. Danigel H, Pflüger KH, Jungclas H, Schmidt L and Dellbrügge J: Drug monitoring of etoposide (VP 16-213). I. A combined method of liquid chromatography and mass spectrometry. Cancer Chemother Pharmacol (1985) 15: 121-124.
18. Fujitaka M, Jinno K, Sakura N, Takata K, Yamasaki T, Inada J, Sakano T, Horino N, Kidani K and Ueda K: Serum concentrations of cortisone and cortisol in premature infants. Metabolism (1997) 46: 518-521.